Distributed Registry
Study Details
Study Description
Brief Summary
The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months. The investigators hope this study to be a "proof of concept" for such a distributed registry and evaluate 1) consistency of data acquisition, 2) engagement of patients, 3) overall value of patient-reported outcomes to enhance long term follow up.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients undergoing vascular surgery procedures Patients will report outcomes via their smartphone. |
Behavioral: Patient reported outcomes
Patients will download the research app onto their phone and enter pertinent medical history and surgical history data similar to standard registries for specific procedures. Over the next 12 months the investigators will obtain patient-reported outcomes (PROs) using the patient's phone.
Specifically, the investigators will obtain daily activity data, weekly 6-minute-walk tests, and quarterly quality of life surveys
|
Outcome Measures
Primary Outcome Measures
- Patient Reported Outcomes (PROs) using mobile app [1 Year]
PROs are any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with cardiovascular disease who are scheduled or have undergone either a) open or endovascular vascular procedure, or b) open or percutaneous cardiac procedure.
-
Patients with smartphones (iOS or Android) with unlimited data plans.
-
Patients who agree to remote surveillance
Exclusion Criteria:
-
Patients unwilling to download a research study app.
-
Data plans which are not unlimited.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Palo Alto Veterans Hospital | Palo Alto | California | United States | 94305 |
2 | Stanford | Palo Alto | California | United States | 94588 |
Sponsors and Collaborators
- Stanford University
- AstraZeneca
Investigators
- Principal Investigator: Oliver O Aalami, MD, Stanford University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB-47517